<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN">
<html>
<head>
  <title>risks</title>
  	<link rel="stylesheet" href="../styles/mystyles.css">
  </head>

<body>
<img src="../images/csg4ed-small.png" alt="Enhancing Social Good in Computing"
<!-- Site navigation menu -->

<ul class="navbar">
  <li><a href="../index.html">Home page</a>
  <li><a href="topic.html">Technology/Topic</a>
	<li><a href="opportunities.html">Opportunities</a>
	<li><a href="misc/risks.html">Risks</a>
	<li><a href="choices.html">Choices</a>
	<li><a href="references.html">References</a>
   <li><a href="process.html">Process Support</a>
</ul>

<!-- Main content -->
<h1>Technology Risks</h1>


</ul><h4><p>Risks in Cost, Scalability, Enforcement.<p></h4>
<p><ul><li>Cost: Putting in place thorough detection systems can be pricey, especially for regulatory agencies with limited funding and smaller pharmaceutical manufacturers.
<br><li>Scalability: It can be difficult to guarantee that detection systems can expand to cover the entire supply chain, particularly in areas with limited infrastructure or regulatory capacity.
<br><li>Enforcement: Requiring close cooperation between regulatory authorities and law enforcement agencies, enforcing regulations and prosecuting counterfeiters can be difficult and
resource-intensive.<br><li>Technological Developments by Counterfeiters: In order to stay ahead, detection systems must constantly innovate and adapt to counter counterfeiters' efforts to
replicate real products.
<br><li>Public Awareness: To raise awareness and ensure widespread adoption, it may be necessary to make significant efforts to promote the use of authentication technologies and educate
the public about the dangers of using fake drugs.
<br><li>Jurisdictional Differences: International collaboration and coordination in the detection and prevention of counterfeit drugs may be hampered by differences in laws and enforcement
procedures between nations.</ul>Despite these difficulties, the advantages of spotting fake drugs and medications outweigh the drawbacks. For a comprehensive and successful strategy to
combat counterfeit drugs, practical applications involving stakeholders from various sectors, including pharmaceutical manufacturers, wholesalers, pharmacies, regulatory authorities,
healthcare professionals, technology providers, consumer organizations, law enforcement agencies, NGOs, and international organizations, are crucial. To find and stop the distribution
of counterfeit drugs, protect public health, and preserve the integrity of the pharmaceutical industry, ongoing collaboration, investments in technology and capacity building, public
awareness campaigns, and international cooperation are essential.
</p>
<address>Made 08 June 2023<br>
  Thomas Nguyen and Ngan Nguyen.</address>
<br><br><br><br><br><br><br><br><br><br>
</body>
 </html>
